Literature DB >> 30203590

Helicobacter pylori and extragastric diseases.

Danute Ražuka-Ebela1, Bianca Giupponi2, Francesco Franceschi2.   

Abstract

Many studies have been performed in the last year concerning the potential role of Helicobacter pylori in different extragastric diseases, reinforcing the idea that specific microorganisms may cause diseases even far from the primary site of infection. While the role of H. pylori on idiopathic thrombocytopenic purpura, sideropenic anemia, and vitamin B12 deficiency has been well established, there is a growing interest in other conditions, such as cardiovascular, neurologic, dermatologic, obstetric, immunologic, and metabolic diseases. Concerning neurologic diseases, there is a great interest in cognitive impairment and neurodegeneration. The aim of this review was to summarize the results of the most relevant studies published over the last year on this fascinating topic.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes mellitus; hepatic encephalopathy; idiopathic thrombocytopenic purpura; iron deficiency anemia; metabolic syndrome; molecular mimicry; nonalcoholic fatty liver disease

Mesh:

Year:  2018        PMID: 30203590     DOI: 10.1111/hel.12520

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  13 in total

1.  On the Association between Gastrointestinal Symptoms and Extragastric Manifestations.

Authors:  G Naoum; S L Markantonis; E Fanerou; G Siagkas; F Petropoulos; E Zafiris; R Kousovista; V Karalis
Journal:  Gastroenterol Res Pract       Date:  2022-06-18       Impact factor: 1.919

2.  The Activity of Liposomal Linolenic Acid Against Helicobacter pylori In Vitro and Its Impact on Human Fecal Bacteria.

Authors:  Ya Wang; Shuang Wu; Le Wang; Youhua Wang; Dongsheng Liu; Yingjun Fu; Yong Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-05-17       Impact factor: 6.073

3.  Helicobacter pylori Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA Study.

Authors:  Nina Wawro; Ute Amann; Julia Butt; Christa Meisinger; Manas K Akmatov; Frank Pessler; Annette Peters; Wolfgang Rathmann; Stefan Kääb; Tim Waterboer; Jakob Linseisen
Journal:  Front Public Health       Date:  2019-04-24

4.  Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study.

Authors:  Jeung Hui Pyo; Hyuk Lee; Sung Chul Choi; Soo Jin Cho; Yoon-Ho Choi; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Heejin Yoo; Kyunga Kim; Jae J Kim
Journal:  Nutrients       Date:  2019-08-12       Impact factor: 5.717

5.  Anti-Glycan Autoantibodies Induced by Helicobacter pylori as a Potential Risk Factor for Myocardial Infarction.

Authors:  Riccardo Negrini; Vincenzo Villanacci; Claudio Poiesi; Antonella Savio
Journal:  Front Immunol       Date:  2020-04-08       Impact factor: 7.561

6.  Impact of Helicobacter pylori infection on fluid duodenal microbial community structure and microbial metabolic pathways.

Authors:  Tadashi Maeda; Hiroaki Zai; Yuto Fukui; Yoshifumi Kato; Eri Kumade; Toshiyasu Watanabe; Norihiro Furusyo; Hitoshi Nakajima; Kazuho Arai; Yoshikazu Ishii; Kazuhiro Tateda; Yoshihisa Urita
Journal:  BMC Microbiol       Date:  2022-01-15       Impact factor: 3.605

7.  Helicobacter pylori infection and risk for developing dementia: an evidence-based meta-analysis of case-control and cohort studies.

Authors:  Nan-Yang Liu; Jia-Hui Sun; Xue-Fan Jiang; Hao Li
Journal:  Aging (Albany NY)       Date:  2021-09-24       Impact factor: 5.682

Review 8.  The effect of Helicobacter pylori eradication on C-reactive protein: results from a meta-analysis.

Authors:  Jun Watanabe; Kazuhiko Kotani
Journal:  Arch Med Sci       Date:  2021-03-21       Impact factor: 3.707

9.  Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study.

Authors:  Chu-Wen Fang; Chun-Hao Chen; Chih-Hsin Muo; Shih-Chi Wu
Journal:  BMC Urol       Date:  2020-08-31       Impact factor: 2.264

10.  Association between nonalcoholic fatty liver disease and Helicobacter pylori infection in Dali City, China.

Authors:  Ping Yan; Bocheng Yu; Min Li; Weidong Zhao
Journal:  Saudi Med J       Date:  2021-07       Impact factor: 1.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.